4//SEC Filing
ONYX PHARMACEUTICALS INC 4
Accession 0001179110-13-012261
CIK 0001012140operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 7:46 PM ET
Size
7.8 KB
Accession
0001179110-13-012261
Insider Transaction Report
Form 4
GRILLO LOPEZ ANTONIO J
Director
Transactions
- Exercise/Conversion
Common Stock
2013-07-26$76.79/sh+2,000$153,580→ 5,600 total - Sale
Common Stock
2013-07-26$130.50/sh−2,000$261,000→ 3,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-07-26−2,000→ 0 totalExercise: $76.79From: 2013-07-25Exp: 2022-07-24→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]Shares sold pursuant to 10b5-1 plan.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012140
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 7:46 PM ET
- Size
- 7.8 KB